Reaction

Abscess Intestinal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,131 reports · 33 co-occurring drugs

As of the last recalculation, Abscess Intestinal appears in 2,131 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is VEDOLIZUMAB (PRR 23.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Vedolizumab	188	23.3	23.3
Metronidazole	99	15.8	15.9
Infliximab-Dyyb	44	15.0	15.0
Adalimumab	681	13.3	13.4
Metronidazole Topical	58	12.2	12.2
Mercaptopurine	21	11.9	11.9
Ustekinumab	118	11.9	11.9
Ciclesonide	16	11.6	11.6
Ciprofloxacin Hydrochloride And Hydrocortisone	24	11.4	11.4
Azathioprine	98	11.3	11.4
Standardized Senna Concentrate	14	10.9	10.9
Mesalamine	61	10.9	10.9
Loperamide Hydrochloride And Dimethicone	35	10.8	10.8
Infliximab	184	8.9	8.9
Ciprofloxacin Hydrochloride	82	8.5	8.5
Budesonide	50	8.5	8.5
Adalimumab-Adaz	44	8.3	8.3
Telmisartan	15	8.3	8.3
Loperamide Hydrochloride	37	8.2	8.2
Adalimumab-Aaty	39	8.2	8.2
Adalimumab-Fkjp	38	8.1	8.1
Ciprofloxacin	73	8.0	8.0
Diphenoxylate Hydrochloride And Atropine Sulfate	11	7.9	7.9
Upadacitinib	59	7.2	7.2
Risankizumab-Rzaa	59	7.2	7.2
Anti-Thymocyte Globulin (Rabbit)	5	6.1	6.1
Lutetium Lu 177 Vipivotide Tetraxetan	8	5.9	6.0
Isotretinoin	26	5.2	5.2
Micafungin Sodium	4	4.6	4.6
Certolizumab Pegol	51	4.3	4.3
Abiraterone	6	4.3	4.3
Minoxidil Foam 5% (Womens)	5	1.5	1.5
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	4	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.